NF-κB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 5, 2000, Pages 1877-1883

  Adib Conquy, M ^a   Adrie, C ^a   Moine, P ^a   Asehnoune, K ^a   Fitting, C ^a   Pinsky, M R ^a   Dhainaut, J F ^a   Cavaillon, J M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR RELA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; INJURY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADOLESCENT; AGED; BLOOD; CELL NUCLEUS; CHEMISTRY; DRUG EFFECT; ELECTROPHORESIS; IN VITRO STUDY; METABOLISM; MIDDLE AGED; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CELL NUCLEUS; CYTOPLASM; ELECTROPHORESIS; FEMALE; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; SEPSIS; TRANSCRIPTION FACTOR RELA; WOUNDS AND INJURIES;

EID: 0033623495     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.5.2003058     Document Type: Article

References (40)

1. Sepsis: A new hypothesis for pathogenesis of the disease process
2. Dys-regulation of in vitro cytokine production by monocytes during sepsis
3. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections
4. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock
5. Decreased serum interleukin-1 activity and monocytes interleukin-1 production in patients with fatal sepsis
6. Cytokine production by monocytes from patients with sepsis syndrome and by endotoxin-tolerant monocytes
7. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis
8. Influence of surgery on in-vitro cytokine production by human monocytes
9. Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline
10. Alteration of monocyte function following major injury
11. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome
12. Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome
13. Inadequate interleukin 2 production: A fundamental immunological deficiency in patients with major burns
14. Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures
15. Downregulation of T helper type I immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparascopic surgery
16. Supression of TNFα mRNA expression in LPS primed macrophages occurs at the level of NF-κB activation, but not at the level of protein kinase C or CD14 expression
17. Induction of endotoxin tolerance depletes nuclear factor-κB and suppresses its activation in rat alveolar macrophages
18. Impaired activation of nuclear factor-κB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation
19. The p65 subunit is responsible for the strong transcription activating potential of NF-κB
20. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and target for v-Rel-mediated repression
21. The candidate oncoprotein Bcl-3 is antagonist of p50/NF-κB-mediated inhibition
22. RelB, a new Rel family transcription activator that can interact with p50-NF-κB
23. Conservation of transcriptional activation functions of the NF-κB p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae
24. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers
25. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites
26. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers
27. Regulation of an essential innate immune response by the p50 subunit of NF-κB
28. A labile transcriptional repressor modulates endotoxin tolerance
29. Inhibitory κBα control of nuclear factor-κB is dysregulated in endotoxin tolerant macrophages
30. Paradoxical priming effects of IL-10 on cytokine production
31. The nonspecific nature of endotoxin tolerance
32. Hyporesponsiveness to lipopolysaccharide alters the composition of NF-κB binding to the regulatory regions of inducible nitric oxide synthase gene
33. Role of NFκB in the mortality of sepsis
34. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
35. Interleukin-10 production during septicaemia
36. The involvement of an LPS inducible IκB kinase in endotoxin tolerance
37. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock
38. Effect of calpain inhibitor I, an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat
39. Elevated interleukin-1 release by human alveolar macrophages during adult respiratory distress syndrome
40. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis